Transient endothelial dysfunction stemming from mental duress was associated with a 78% increase in the incidence of MACE in a study of patients with stable CAD, providing scientists with a look at just how much psychological stress can influence our risk of CVD.

A poll conducted by researchers at Fairleigh Dickinson University in New Jersey has revealed that a quarter of Americans take daily low-dose aspirin at some point in their lives, but the majority of those people don’t have heart disease or another chronic illness.

Victims of cardiac arrest are more likely to recover with good brain function if they’re subject to “cooling” after resuscitation, UPI.com reported via HealthDay News Oct. 2.

Cardiac radiation dose exposure is a modifiable cardiac risk factor for major cardiac adverse events and all-cause mortality in patients undergoing radiotherapy for non-small-cell lung cancer, researchers report in the Journal of the American Heart Association.

Patients with severe aortic stenosis who undergo TAVR enjoy a minor but significant sustained health benefit that isn’t mirrored in patients who opt for surgical AVR, according to research reported at TCT 2019 in San Francisco.

Sleeping less than six hours a night could significantly raise a person’s risk of cancer or early death if they’re middle-aged and have high blood pressure, type 2 diabetes, heart disease or a history of stroke, according to work published in the Journal of the American Heart Association.

An updated meta-analysis centered around the role marine omega-3 supplementation in CVD prevention suggests there may be a use for fish oil in cardiovascular medicine after all.

The FDA approved canagliflozin Sept. 30 to reduce the risk of end-stage kidney disease, worsening kidney function, CV death and hospitalization for heart failure in adults with type 2 diabetes and diabetic nephropathy.